Private equity fundraising struggled in 2024, with total capital raised declining for the third consecutive year. Read more ...

ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn's disease <li /> New detailed data from ...

One of the largest pharmaceutical companies in North Carolina is discontinuing a treatment produced in the state.

This analysis was conceived by its author as a trilogy of commentaries in the wake of Decision 16/2 from the 16th Conference ...

The US Food and Drug Administration (FDA) has granted 510(k) clearance to the BioCharge Autobiologic Matrix, a bioresorbable ...

With the robust demand for personalized medicines and the growing adoption of digital technology, the precision medicine ...

Teva Pharmaceuticals and Alvotech said on Friday they have launched a biosimilar to Johnson & Johnson's autoimmune drug ...

A bill that would shield pesticide companies from label-related lawsuits, provided the company adhered to federal label ...

The health sector is facing significant changes, with the FDA restricting language, New York suing e-cigarette makers, AstraZeneca expanding in China, Eli Lilly stockpiling weight-loss drugs, Teva and ...

Recalls in the food and beverage industry due to contamination incidents can be catastrophic for a company. Not only do ...

The creature is being trafficked across Africa and Asia to fuel a steady demand for their scales, an ingredient in unproven ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system ...